MedTrace Logo

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

NCT01288625 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-11-17

No results posted yet for this study

Summary

The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.

Conditions

Interventions

DRUG

Amifostine

500 mg sc, qod, 3 times per week

RADIATION

Amifostine

500mg rinsing wash, qod, 3 times per week

Sponsors & Collaborators

  • Sun Pharmaceutical Industries Limited

    lead INDUSTRY

Principal Investigators

  • Wang ge · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288625 on ClinicalTrials.gov